Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Hepatocellular 131 Liver Neoplasms 42 Carcinoma, Renal Cell 36 Leukemia, Myeloid, Acute 32 Neoplasm Metastasis 26 Breast Neoplasms 24 Carcinoma, Non-Small-Cell Lung 22 Kidney Neoplasms 16 Neoplasms 14 Prostatic Neoplasms 12 Pancreatic Neoplasms 12 Recurrence 11 Lung Neoplasms 11 Colorectal Neoplasms 10 Sarcoma 9 Melanoma 9 Brain Neoplasms 9 Myelodysplastic Syndromes 8 Glioblastoma 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Leukemia 6 Urinary Bladder Neoplasms 5 Thyroid Neoplasms 5 Rectal Neoplasms 5 Multiple Myeloma 5 Leukemia, Myelomonocytic, Chronic 5 Stomach Neoplasms 4 Ovarian Neoplasms 4 Liver Diseases 4 Gliosarcoma 4

Interventions

Surveys and Questionnaires 7 Standard of Care 5 Sirolimus 5 Bevacizumab 5 temsirolimus 4 Interviews as Topic 4 Paclitaxel 3 olaparib 2 Vorinostat 2 Olanzapine 2 Magnetic Resonance Spectroscopy 2 Gemcitabine 2 Everolimus 2 Erlotinib Hydrochloride 2 Dasatinib 2 Cetuximab 2 zaleplon 1 vistusertib 1 tilsotolimod 1 pazopanib 1 olanzapine-fluoxetine combination 1 nimotuzumab 1 liposomal doxorubicin 1 capivasertib 1 apatinib 1 Videotape Recording 1 Vemurafenib 1 Valproic Acid 1 Trastuzumab 1 Topotecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Advanced Cancer × Sorafenib × Clear all

NCT00543504 2020-06-30

Bevacizumab in Multiple Phase I Combinations

M.D. Anderson Cancer Center

Phase 1 Completed

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡